Search clinical trials for: KD-247

Total 1360 results

The Chemo-Sero-Therapeutic Research Institute

Completed

A Study of Anti-HIV Monoclonal Antibody KD-247

HIV Infections

United States
Université de Sherbrooke

Completed

PET Study of Cerebral Metabolism of 11C-acetoacetate and 18F-FDG in Patients Under Moderate Ketosis (TEP-KD)

Healthy
Peking University
KAEDI

Not yet recruiting

NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor

Gastric Cancer | Pancreatic Cancer | Solid Tumor

China
jianming xu
KAEDI

Recruiting

NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors

Gastric Cancer | Pancreatic Cancer | Solid Tumor

China
jianming xu
KAEDI

Recruiting

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Solid Tumor | CRC

China
UMC Utrecht

Not yet recruiting

Grip on Knee Osteoarthritis; DIstraction Versus Arthroplasty (GODIVA)

Knee Osteoarthritis
Procare Health Iberia S.L.

Completed

Evaluate Clinical Benefit of Local Treatment With KD Intra-Articular® Gel in Patients With Osteoarthritis (NO-DOLOR2) (NO-DOLOR2)

Osteoarthritis, Hip | Osteoarthritis Thumb | Osteoarthritis Ankle

Spain
The Affiliated Nanjing Drum Tower Hospital of Nanjing...
KAEDI

Not yet recruiting

NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors

Glioma | Hepatocellular Carcinoma | Colorectal Cancer | Solid Tumor

China
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Active, not recruiting

A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients

Endometrial Cancer

United States
Kuopio University Hospital
Deakin University

Recruiting

Ketogenic Diet for Psychotic Disorders (PsyDiet)

Psychotic Disorders | Schizophrenia | Psychosis | Psychosis; Acute

Finland
National Institute on Alcohol Abuse and Alcoholism...

Completed

Ketogenic Diet (KD) in Alcoholism

Alcoholism

United States
Jiujiang University Affiliated Hospital
KAEDI

Withdrawn

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Glioblastoma | Hepatocellular Carcinoma | Medulloblastoma | Colon Cancer

China
University of Illinois at Chicago
Patient-Centered Outcomes Research Institute

Completed

Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease (PCMH-KD)

ESRD

United States
UConn Health

Completed

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

Leukemia

United States
Yan'an Affiliated Hospital of Kunming Medical University
KAEDI

Unknown

CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia

B Cell Lymphoma | B-cell Acute Lymphoblastic Leukemia

China
AgonOx, Inc.
Providence St Joseph Health; Phio Pharmaceuticals Corp.

Recruiting

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors (ACT)

Melanoma | Gynecologic Cancer | Colorectal Cancer | Lung Cancer | HNSCC | Urogenital Cancer

United States
University of Padova

Completed

Effects of a Ketogenic Diet on Psychological Outcomes

Overweight | Mood | Appetitive Behavior

Italy
Centre Hospitalier Universitaire de Nīmes

Recruiting

Impact on Mortality of Screening for Kidney Disease Associated With a Specialized Intervention During Hospitalization in a Territorial Hospital Trust (WARNING KD)

Chronic Kidney Diseases | Acute Kidney Injury

France
Poznan University of Life Sciences
Poznan University of PhysED

Unknown

Effect of Ketogenic and Carbohydrate Diet in Crossfit

Nutrition | Ketogenic Dieting | Sport | Low Glycemic Index Diet | Crossfit

Poland
ESM Technologies, LLC
QPS Bio-Kinetic; KD Pharma Group

Completed

NEM® + KD PUR® Fish Oil Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women (Move3)

Exercise-induced Joint Pain | Exercise-induced Joint Stiffness | Exercise-induced Joint Cartilage Turnover

United States
Azienda Sanitaria ASL Avellino 2

Unknown

Renal Effects of Meditarranean Diet and Low-protein Diet With Ketoacids on Physiological Intestinal Mibrobiota in CKD (MEDIKA)

Chronic Renal Insufficiency

Italy
Healthpoint

Unknown

Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer

Venous Leg Ulcer

United States, Canada
Healthpoint

Completed

Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds

Normal Female Volunteers

United States
Healthpoint

Terminated

A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers (MOA 034)

Venous Leg Ulcers

United States
Universitätsmedizin Mannheim

Completed

Ketogenic Or LOGI Diet In a Breast Cancer Rehabilitation Intervention (KOLIBRI) (KOLIBRI)

Quality of Life

Germany
Healthpoint

Terminated

Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers

Ulcer | Venous Ulcer | Venous Stasis Ulcer

Germany, Poland, Belgium, Czech Republic, Hungary
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Fred Hutchinson Cancer Center
Sanofi

Recruiting

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease

United States
Healthpoint

Completed

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

Venous Leg Ulcers

United States, Canada, Puerto Rico
Healthpoint

Withdrawn

A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa
Healthpoint

Completed

Dose Finding Study of HP802-247 in Venous Leg Ulcers

Venous Leg Ulcer | Venous Stasis Ulcers

United States, Canada
Healthpoint
Smith & Nephew, Inc.

Completed

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

Venous Leg Ulcers

United States, Canada
University of British Columbia
Weston Family Foundation

Not yet recruiting

Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome (KIM)

Parkinson Disease
Atlantic Health System

Unknown

Trial of Compassionate Use of hp802-247 to Treat Venous Leg Ulcers in Subjects Who Have Failed Multiple Other Healing Technologies

Venous Leg Ulcer

United States
Amgen

Terminated

Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (20170528)

Relapsed/Refractory Acute Myeloid Leukemia (AML)

United States, Korea, Republic of, Australia, Japan, Germany, Canada
JMackem Co., Ltd
Seoul National University Hospital

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Diabetic Neuropathies | Neuropathic Pain | Post Herpetic Neuralgia

Korea, Republic of
Memorial Sloan Kettering Cancer Center
University of Pisa; University of California, San Francisco; The Champalimaud...

Active, not recruiting

Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy

Melanoma | Sarcoma | Ovarian Cancer | Bone | Soft Tissue | Lymph Nodes | CNS-Spinal CD/MEMBR, NOS

United States, Italy, Portugal
Merz Pharmaceuticals GmbH

Completed

IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity (NT-Spin)

Upper Limb Spasticity

France, Spain, Switzerland, United Kingdom, Italy, Austria, Germany, Portugal
Celltrion

Not yet recruiting

A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis
National Cancer Institute (NCI)

Not yet recruiting

TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory High Risk Myelodysplastic Syndrome
Boehringer Ingelheim

Completed

Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects

Healthy
Gesynta Pharma AB
CTC Clinical Trial Consultants AB; RISE Research Institutes of Sweden AB

Completed

A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248

Pharmacokinetic

Sweden
SIGA Technologies
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers (SIGA-246-002)

Healthy

United States
The University of Texas Health Science Center,...
National Institute on Disability, Independent Living, and Rehabilitation...

Recruiting

A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 3)

Pain Management

United States
Johann Wolfgang Goethe University Hospital

Completed

Comparison of the Guide-wire G-240 to a Combination of a Flexible/Hydrophil and a Nitinol Guide Wire

Other Specified Diseases of Biliary Tract

Germany
SIGA Technologies
National Institutes of Health (NIH)

Completed

Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246 (246-Safety)

Orthopoxviral Disease

United States
Orion Corporation, Orion Pharma

Completed

ODM-207 in Patients With Advance Solid Tumours (BETIDES)

Solid Tumors

Finland
Aprea Therapeutics

Completed

Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer

Prostatic Neoplasms | Hematologic Neoplasms

Sweden
MedImmune LLC

Terminated

Study of MEDI-547 to Evaluate the Safety, Tolerability, and Biologic Activity of IV Administration in Subjects With Relapsed or Refractory Solid Tumors (MEDI-547)

Cancer

United States
Kyowa Hakko Kirin UK, Ltd.

Completed

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

Multiple Myeloma | Chronic Lymphocytic Leukaemia | B-cell Non-Hodgkin's Lymphoma

United Kingdom

Search clinical trials for: KD-247

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations